With a professional research team and core technologies, Innolcon is dedicated to R&D, manufacturing, sales and services of high-end surgical instruments and high-value medical consumables including ultrasonic surgical platform, electrical energy platform, ophthalmic surgical instruments and versatile surgical robots. Now, Innolcon is growing into the domestic leader in the field of surgical technology and products.
The ultrasonic surgical system (Ultrasonic Scalpel) is a groundbreaking piece of clinical surgical system that uses ultrasonic energy to promote hemostatic cutting and coagulation of soft tissues. It can be used to cut soft tissue other than bone tissue and reversiable fallopian tubal ligation, as well as to cut and seal vessels up to 5mm in diameter. It has been widely applied in a variety of open and endoscopic surgeries.
Learn More
Our products are creating value in more than 60 countries and regions around the world, including Brazil, South Korea, Italy, Spain, France, Belgium, etc.
+ More DetailsCountries
On July 22, Li Hui, deputy general manager of Shenzhen Stock Exchange, visited our company for research and guidance, accompanied by relevant leaders of Shenzhen Stock Exchange in Shanghai Center and Zhu Xiaoyan
On December 15, 2021, Innolcon Medical Technology (Hefei) Co., Ltd. was officially established, and on July 12, 2022, Innolcon Hefei successfully completed pilot production of the first batch of ultrasonic scalpels.
Founded on June 18, 2014, Innolcon cares for life and health through continuous improvement in product performance and quality. Staying true to its original aspiration "Satisfying surgeons and benefiting patients around the world with high quality products", Innolcon strives to forge ahead and provide more advanced medical devices for the world.
